|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 500 articles |
 Page 1 of 7 
|
Speedel's Nick Miles steps down as communications chief.
February 25, 2008
Chemo Iberica considers US acquisition.
February 25, 2008
Wyeth granted summary judgement in vaccines case.
February 25, 2008
Watson names Francois Menard as SVP of genetics R&D.
February 25, 2008
Jacques Arend named as VP of clinical development at AM-Pharma.
February 25, 2008
Almirall names Carlos Gallardo as general manager, UK and Ireland.
February 25, 2008
Novartis and Novo Nordisk sue over patent infringement on Bayer's Koge...
February 25, 2008
Japan's MHLW grants Revlimid orphan status for two different indicatio...
February 25, 2008
SSI licenses fusion proteins to Sanofi Pasteur for development of TB v...
February 25, 2008
Memory/Roche's MEM 3454 enters schizophrenia biomarker study.
February 25, 2008
FDA gives Boehringer Ingelheim's BIBW 2992 fast track designation.
February 25, 2008
EMEA grants orphan status to SYGNIS' ALS drug.
February 25, 2008
FDA accepts NDA for Kissei's BPH drug.
February 25, 2008
Ph III Trovax data in renal cancer expected 2009.
February 25, 2008
UPDATE: Bayer and Onyx halt Nexavar trial in NSCLC.
February 25, 2008
Xyzal oral solution cleared by US FDA.
February 25, 2008
FDA Treanda decision expected end-October.
February 25, 2008
UPDATE: GPhA sees US prospects in 2008, Rx share at 65%.
February 25, 2008
Pfizer sponsors African anti-fake drug event.(Conference news)
February 25, 2008
Scientists at Stanford University find protein targets for MS.
February 25, 2008
Japan making no real changes in Rx pharma pricing, says DR.
February 25, 2008
Affimed increases series B financing round to 30M euros.
February 25, 2008
PuriCore to buy ECT's patent portfolio.
February 25, 2008
NWBT's DCVax impresses in Phase I/II studies.
February 25, 2008
Pinnacle and MedImmune sign Ethyol distribution deal.
February 25, 2008
Genetix launches CytoGentix reagents.
February 25, 2008
FDA panel recommends GSK's rotavirus vacc.
February 25, 2008
FDA says clerical mix-up led to heparin plant inspection failure.
February 25, 2008
GSK cuts HIV drug prices for world's poorest countries.
February 25, 2008
Drugmakers train reps in hospital IDN to boost sales.
February 25, 2008
Stock Commentary - Europe - week to Feb 18, 2008.
February 25, 2008
Stock Commentary - New York week to Feb 18, 2008.
February 25, 2008
Preclinical data: SIRT1 activation suppresses tumor growth.
February 25, 2008
Lab21 licenses Celera's HCV test for UK and Ireland.
February 25, 2008
Promising PKC data on AGI's IBS-D drug.
February 25, 2008
Astellas extends MorphoSys accord to 2012.
February 25, 2008
Millennium expands Velcade program in NHL.
February 25, 2008
Sunesis gets milestone in J&J accord.
February 25, 2008
Australia's Biota buys back shares.
February 25, 2008
Novozymes and Upperton extend deal.
February 25, 2008
Algeta to start US Alpharadin trials.
February 25, 2008
Pharma seen as good employer, survey finds.
February 25, 2008
Alex Gorsky leaves Novartis to join J&J's Ethicon.
February 25, 2008
Novo Nordisk names Pamela Harris as VP of diabetes sales.
February 25, 2008
Simon Sturge steps down as Vernalis CEO.
February 25, 2008
Helge Bastian joins Sigma-Aldrich as VP of global marketing operations...
February 25, 2008
CORRECTION: P&G's Asacol trial.(Correction notice)
February 25, 2008
Invitrogen takes minority stake in Q Thera.
February 25, 2008
More Americans are using greater number of prescription drugs; survey.
February 25, 2008
New risks pharma and biotech face from payers' focus on health care va...
February 25, 2008
Lixivaptan in Ph III hyponatremia and heart failure trial.
February 25, 2008
OncoGenex' OGX-011 meets endpoint in Ph II cancer study.(Clinical repo...
February 25, 2008
AstraZeneca files Seroquel for MDD with MHRA.
February 25, 2008
Riken team develops infinite RBC production method.
February 25, 2008
One-third of malaria cases cut by vit A and zinc.
February 25, 2008
Cephalon's 2007 sales beat its expectations.
February 25, 2008
Generic Rxing hits 65% of US market.
February 25, 2008
US govt campaign against Rx drug abuse.
February 25, 2008
Israel's Optimata secures $1.5M in placing.
February 25, 2008
Alexion gains rights to Soliris-related patents for $10M.
February 25, 2008
Cadence Pharma to raise $49.3M.
February 25, 2008
Sanofi Pasteur teams up with Denmark's SSI for TB vaccines.
February 25, 2008
Call for US FDA Commissioner to resign over Ketek and heparin oversigh...
February 25, 2008
Merck KGaA revenues, core EPS rocket but 4th-qtr operating results slu...
February 25, 2008
Japanese pharma companies are steadily penetrating global markets.
February 25, 2008
Japan's Chuikyo recommends introduction of generic prescription format...
February 25, 2008
Bayer/Onyx halt Nexavar trial in NSCLC.
February 25, 2008
GSK's ofatumumab impresses in CLL trial.
February 25, 2008
Avastin improves PFS in breast cancer.
February 25, 2008
Kaletra impressive 48-week HIV reduction.
February 25, 2008
Retigabine effective in Ph III epilepsy trial.
February 25, 2008
ImmunoCellular completes MDC acquisition.
February 25, 2008
JADO reports positive Ph IIa trial with TF002.(Clinical report)
February 25, 2008
US PBM pays $38.5M to settle rebate dispute.
February 25, 2008
Dispute over Gates Foundation control of malaria drug R&D.
February 25, 2008
|
1